bpc-157 safety human studies adverse effects BPC-157: Experimental Peptide Creates Risk for Athletes BPC-157: A Prohibited Peptide and
Description
There is currently no approved human therapeutic use

For patients requiring additional therapeutic effect, the dose may be increased to 1 mg of semaglutide weekly after at least four weeks at the 0.5 mg dose
C., de Moraes, R
Many clients incorporate wellness injections into their ongoing self-care or pair them with body sculpting or skin treatments

The buying decision comes down to reading the full listing, not just one number
